| Heidi V Yabut, LPN | |
|
670 W Fireweed Ln Ste 160, Anchorage, AK 99503-2561 | |
| (907) 770-0862 | |
| Not Available |
| Full Name | Heidi V Yabut |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 670 W Fireweed Ln Ste 160, Anchorage, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811670813 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 133565 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Heidi V Yabut, LPN 11761 Spyglass Cir, Anchorage, AK 99515-2706 Ph: (907) 978-6448 | Heidi V Yabut, LPN 670 W Fireweed Ln Ste 160, Anchorage, AK 99503-2561 Ph: (907) 770-0862 |
News Archive
For the last seven years, researchers in the UPV/EHU's Department of Physical and Sports Education have been studying the hypertensive population with excess weight/obesity and sedentary habits. In a recent publication, this group has determined the state of health of this population through various key physical, physiological, clinical and nutritional markers and has separated them by sex and physical condition.
Resverlogix Corp. announces that the Company's Phase 2 clinical trial, called ASSURE (ApoA-1 Synthesis Stimulation in Acute Coronary Syndrome patients), has made important modifications to the design of the trial which have the potential to demonstrate a more powerful endpoint for the planning of future clinical trials for RVX-208.
In health care reform discussions, talk inevitably turns to making hospitals and physicians accountable for patient outcomes. But in a commentary being published in the July 14 issue of the Journal of the American Medical Association, Johns Hopkins patient safety expert Peter Pronovost, M.D., Ph.D., argues that the health care industry doesn't yet have measurable, achievable and routine ways to prevent patient harm — and that, in many cases, there are too many barriers in the way to attain them.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the chronic pain drug market will experience modest four percent annual growth from 2008 to 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Although the market will increase over the next decade, generic erosion will constrain sales of key branded agents such as Johnson & Johnson's Topamax (topiramate) and Pfizer's Celebrex (celecoxib).
› Verified 6 days ago
Ms. Dessie Natillia Cooper, RN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 711 H St Ste 100, Anchorage, AK 99501 Phone: 907-770-0862 | |
Cynthia Kelly, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 670 W Fireweed Ln Ste 160, Anchorage, AK 99503 Phone: 907-770-0862 | |
Eteva Tautu, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6916 Windsor Pl, Anchorage, AK 99502 Phone: 907-885-7624 | |
Nicholas Morley, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 121 W Fireweed Ln Ste 105, Anchorage, AK 99503 Phone: 907-865-9653 Fax: 907-865-9124 | |
Ms. Susie Ann Edwards, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-1729 | |
Stephanie Louise Melendez, LVN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 670 W Fireweed Ln Ste 160, Anchorage, AK 99503 Phone: 907-770-0862 | |
Naomi Caskey, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 670 W Fireweed Ln Ste 160, Anchorage, AK 99503 Phone: 907-770-0862 |